Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone and Lidocaine for Hemorrhoids
NCT02689856Phase 2Completed
- Sponsor
- Citius Pharmaceuticals, Inc.
- Start
- May 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of hydrocortisone and lidocaine hydrochloride gel 2% in Hemorrhoids (7 arms), sponsored by Citius Pharmaceuticals, Inc. Primary endpoint: Global Score of Disease Severity at 14 days. Started May 2015; status: completed.
02
Drugs
hydrocortisonelidocaine hydrochloride gel 2%
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT02689856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689856.